Fig. 4From: Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panelVariants detected in the clinical MPN samples with VAF > 5%. Note that Sample 02 also carries another variant in TET2 with a VAF of 1.4% (not shown in Fig. 4)Back to article page